Logos Global Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Logos Global Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,600,000	Closed	-$22.8M	–	72
2021 Q4	$22.8M	Sell	1,600,000 -515,000	-24%	-$8.91M	2.35%	15
2021 Q3	$49M	Buy	2,115,000 +900,000	+74%	+$21.3M	3.54%	7
2021 Q2	$30.2M	Sell	1,215,000 -195,000	-14%	-$5.24M	2.54%	14
2021 Q1	$39.5M	Buy	1,410,000 +10,000	+0.7%	+$361K	3.86%	7
2020 Q4	$48.9M	Buy	1,400,000 +226,812	+19%	+$9.87M	4.19%	4
2020 Q3	$58.5M	Sell	1,173,188 -106,812	-8%	-$4.32M	7.48%	4
2020 Q2	$59.5M	Buy	+1,280,000	New	+$55.5M	11.89%	1

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Logos Global Management's FMTX Position: Q1 2022 in Review

Logos Global Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022, closing a stake of 1,600,000 shares — an estimated $22.8M sold.

Logos Global Management first reported a position in FMTX in Q2 2020 and held it in 7 quarters. The position peaked at $59.5M in Q2 2020. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

Logos Global Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Logos Global Management sold 1,600,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $22.8M.
Logos Global Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Logos Global Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $59.5M in Q2 2020.
98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Logos Global Management's 13F filing for Q1 2022, filed 16 May 2022.